Response to Miller et al: resistant mutations in CML and Ph(+) ALL - role of ponatinib

Related Experiment Videos

Nathalie Bardy-Bouxin1, Ewa Matczak1, Geeta Devgan1

  • 1Pfizer Oncology, Pfizer Inc., New York, NY, USA.

Biologics : Targets & Therapy
|March 4, 2015
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos